GlassScriptPhysician profile
Nicole Ouellette
NPI 1568975969
$21,007.27
in general payments reported to CMS, 2019-2025
54 companies · $4,779 in 2025
The $4,779 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,137 · 2022: $4,472 · 2023: $4,997 · 2024: $5,621 · 2025: $4,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $34.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,364.06 |
| Education | $34.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,214.40 | 2021-2025 | |
| Lundbeck LLC | $1,545.30 | 2021-2025 | Vyepti, Rexulti |
| Sk Life Science, INC. | $1,481.91 | 2022-2025 | Xcopri |
| Emd Serono, INC. | $1,283.67 | 2021-2025 | Mavenclad |
| Biogen, INC. | $994.10 | 2022-2025 | Tysabri, Vumerity, Skyclarys |
| Merz Pharmaceuticals, LLC | $984.32 | 2021-2025 | Xeomin |
| Pfizer INC. | $941.70 | 2023-2025 | |
| Lilly USA, LLC | $860.28 | 2021-2025 | Kisunla, Emgality, Reyvow |
| Alexion Pharmaceuticals, INC. | $731.39 | 2022-2025 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $688.84 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $676.69 | 2021-2023 | Ponvory |
| Celgene Corporation | $609.22 | 2021-2024 | Zeposia |
| Neurelis, INC. | $591.95 | 2021-2025 | Valtoco |
| Genzyme Corporation | $494.20 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $493.02 | 2021-2025 | Ongentys, Rytary, Lyvispah |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $484.96 | 2022-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Teva Pharmaceuticals USA, INC. | $417.28 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Csl Behring | $414.32 | 2022-2025 | Hizentra |
| Neurocrine Biosciences, INC. | $414.08 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $376.83 | 2022 | |
| Ucb, INC. | $329.55 | 2022-2025 | Rystiggo, Zilbrysq, Nayzilam |
| Livanova USA, INC. | $308.84 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Eisai INC. | $297.29 | 2022-2025 | |
| Amgen INC. | $268.51 | 2022-2025 | Aimovig, Uplizna |
| Vanda Pharmaceuticals INC. | $257.89 | 2021-2025 | Ponvory |
| Sumitomo Pharma America, INC. | $256.21 | 2023-2024 | Aptiom |
| Kyowa Kirin, INC. | $217.48 | 2021-2024 | Nourianz |
| Mdd US Operations, LLC | $209.70 | 2022-2025 | Gocovri, Apokyn, Apokyn |
| Grifols USA, LLC | $195.75 | 2021-2025 | Gamunex-C |
| Inspire Medical Systems, INC. | $194.29 | 2024-2025 | Inspire |
| Argenx US, INC. | $173.35 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Mallinckrodt Hospital Products INC. | $159.27 | 2022-2024 | Acthar |
| Acadia Pharmaceuticals INC | $146.65 | 2022-2025 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $136.26 | 2023-2025 | Rexulti, Nuedexta |
| Sunovion Pharmaceuticals INC. | $123.34 | 2022 | |
| Acorda Therapeutics, INC | $118.29 | 2022-2023 | Inbrija |
| Janssen Biotech, INC. | $118.20 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $95.17 | 2021 | |
| Ani Pharmaceuticals, INC. | $90.42 | 2023-2025 | Purified Cortrophin Gel |
| Ipsen Biopharmaceuticals, INC | $87.20 | 2023-2025 | Dysport |
| Organogenesis INC. | $81.96 | 2023 | Puraply |
| Xeris Pharmaceuticals, INC. | $79.91 | 2023-2025 | Keveyis |
| Impel Pharmaceuticals INC. | $72.31 | 2023 | Trudhesa |
| Catalyst Pharmaceuticals, INC. | $54.40 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $47.90 | 2022 | |
| Avion Pharmaceuticals | $36.61 | 2022-2023 | Dhivy |
| Life Molecular Imaging LTD | $26.81 | 2023-2024 | Neuraceq |
| Allergan, INC. | $23.61 | 2021 | |
| Tanabe Pharma America, INC. | $22.67 | 2024 | |
| Microtransponder, INC. | $19.53 | 2025 | |
| Upsher-Smith Laboratories LLC | $17.15 | 2022 | |
| Straumann USA LLC | $16.34 | 2023 | |
| Watermark Medical, INC. | $13.47 | 2024 | |
| Banner Life Sciences, LLC | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Ouellette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.